Skip to content
Operation Infinite Justice – Lifestyle
Author:
Mapi Pharma
Mapi Pharma to Participate in the ASCO Annual Meeting and ADA 2026 Scientific Sessions
June 1, 2026
Mapi Pharma Explores U.S. Aseptic Manufacturing Facility to Support Growing Demand for Aseptic and Long-Acting Generic and innovative Injectables
May 4, 2026
Mapi Pharma to Present Efficacy (EDSS) Data from Glatiramer Acetate Depot Long-Acting Injection Studies in Relapsing Forms of Multiple Sclerosis (RMS) and Primary Progressive Multiple Sclerosis (PPMS) at AAN 2026
April 16, 2026